Baraclude FDA Approval History
FDA Approved: Yes (First approved March 29, 2005)
Brand name: Baraclude
Generic name: entecavir
Dosage form: Tablets / Oral Solution
Company: Bristol-Myers Squibb Company
Treatment for: Hepatitis B
Baraclude (entecavir) is a nucleoside analogue oral antiviral therapy for the treatment of chronic hepatitis B in adults.
Development timeline for Baraclude
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.